English
This article is from The Journal of Biological Chemistry , volume 289 . Abstract Background: IL-6 signaling is a key component of inflammatory diseases.Results: Modified DNA aptamers that inhibit IL-6 signaling were discovered and optimized.Conclusion: Modified aptamers are stable in serum and block the interaction of IL-6 with its receptor IL-6Rα.Significance: Modified aptamers are a new class of antagonist with properties potentially suitable for clinical treatment of inflammation.
Sign in with your free account to read, download EPUBs or listen.
Ebook · Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor. · Gupta, Shashi, Hirota, Masao, Waugh, Sheela M., Murakami, Ikuo, Suzuki, Tomoki, Muraguchi, Masahiro, Shibamori, Masafumi, Ishikawa, Yuichi · Internet Archive